Matrix Capital Management Company, LP

CIK 1410830 · View on SEC EDGAR ↗

Portfolio value
$46.3M
#8,744 of 9,443 by 13F value · top 92.6%
Positions
1
As of
March 31, 2026 Data as of Q1 2026

Portfolio value QoQ: -19.6% 13F does not disclose cash

Top 10 holdings weight
100.00%
Top 25 holdings weight
100.00%
Positions above 1%
1
Effective number of positions
1.0

Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)

Turnover Q1 2026: 0.0% Est. buys $0 · sells $19,886,400

Median holding: 3.5 quarters Tracked Q4 2024–Q1 2026 · 16.7% still held

New positions
0
Increased
0
Decreased
0
Closed
1
On this page

Performance vs S&P 500

Tracked Q1 2025–Q1 2026
+43.6%
S&P 500 total return (same window)
+19.3%
Excess return
+24.3%

Annualized: +43.6% · S&P 500: +19.3%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 100.0% · Options excluded: 0.0%

Sector breakdown

Healthcare
100.0%

Full portfolio 1 positions

Type Streak 8Q trend
AURA Aura Biosciences, Inc. - Common Stock $46,314,000 100.00% 6,922,870 $8,584,358

Top movers (QoQ)

Security Action Shares Δ Value Δ
AURA Price move only +0 +$8.6M

Exited positions

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

SecurityQuarter Shares before Value before Price since exit
ALTR March 31, 2025 12,430,000 $1,356,237,300 No longer tracked
GFS Sept. 30, 2025 3,475,000 $132,745,000 32.4%
PRM March 31, 2025 6,554,000 $83,760,120 209.9%
ZNTL Dec. 31, 2025 13,959,973 $21,079,559 187.4%
MAZE March 31, 2026 480,000 $19,886,400 -2.6%